No adverse events or immune system reactions were seen in patients with Type 1 diabetes who were transplanted with encapsulated pig pancreatic cells, according to a New Zealand study. After the treatment, two people were able to halt insulin shots for four weeks and 32 weeks, respectively, while others were able to lessen their daily insulin needs, the study also showed. The transplanted cells work by producing insulin in response to the high sugar levels in the patients' blood.

Related Summaries